ESC 365 - Low-dose interleukin-2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY) / IVORY - Clinical Outcomes And Follow-up (IVORY FINALE) Study

Back

ESC Professional Premium Access

Low-dose interleukin-2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY) / IVORY - Clinical Outcomes And Follow-up (IVORY FINALE) Study

Session: Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease

Topic: Pharmacotherapy

Speaker: Doctor R. Sriranjan (Cambridge, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Rouchelle Sriranjan

Royal Papworth Hospital, Cambridge (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

7 more presentations in this session

Anakinra versus placebo double blind Randomized controlled trial for the treatment of Acute MyocarditIS

Speaker: Professor M. Kerneis (Paris, FR)

Access

Slides

Video

Colchicine for secondary prevention of stroke and other cardiovascular events: a meta-analysis of randomised trials

Speaker: Mr A. Fiolet (Utrecht, NL)

Access

Slides

Video

Cardiovascular benefit of colchicine in relation to baseline risk

Speaker: Mr N. Mohammadnia (Nijmegen, NL)

Access

Slides

Video

Effect of pre-hospital pulse-dose glucocorticoid on infarct size in st-segment elevation myocardial infarction: a randomized, blinded, placebo-controlled clinical trial

Speaker: Doctor J. Madsen (Copenhagen, DK)

Access

Slides

Video

Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure

Speaker: Professor D. Pascual Figal (Murcia, ES)

Access

Slides

Video

Access the full session

Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease

Speakers: Doctor R. Sriranjan, Professor M. Kerneis, Mr A. Fiolet, Mr N. Mohammadnia, Doctor J. Madsen...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources